+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

From
From
Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
From
Myelofibrosis - Pipeline Insight, 2026 - Product Thumbnail Image

Myelofibrosis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 180 Pages
  • Global
From
From
Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2026 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
From
High Potency APIs (HPAPIs) - Global Strategic Business Report - Product Thumbnail Image

High Potency APIs (HPAPIs) - Global Strategic Business Report

  • Report
  • August 2026
  • 218 Pages
  • Global
From
Sustained Release Excipients - Global Strategic Business Report - Product Thumbnail Image

Sustained Release Excipients - Global Strategic Business Report

  • Report
  • August 2026
  • 136 Pages
  • Global
From
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)- Pipeline Insight, 2025 - Product Thumbnail Image

EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator